Fenofibrate dispersible tablets instructions recommended dosage is: oral, 0.1g each time, 3 times a day, maintenance dose of 0.1g each time, 1 to 2 times a day. Renal insufficiency and elderly patients with medication should be appropriately reduced under the guidance of a doctor; in order to reduce gastric discomfort, it is recommended that patients take with diet; if the patient is ineffective after 2 months of treatment, the drug should be discontinued. Fenofibrate Dispersible Tablets are mainly used for the treatment of hyperlipidemia in adult patients with poor effect of diet control therapy. Adverse reactions to Fenofibrate Dispersible Tablets include: gastrointestinal reactions, such as abdominal discomfort, diarrhea, and constipation; skin reactions, such as rash; neurological, such as malaise, headache, loss of libido, impotence, dizziness, and insomnia; hematological alterations, such as lowering of hemoglobin, hematocrit, and leukocytes; and occasional increases in blood aminotransferases. The drug may also cause myositis, myopathy and rhabdomyolysis syndrome, resulting in elevated blood creatine phosphokinase; the drug has a tendency to increase gallstones, which can cause gallbladder disease and even require surgery. In addition, Fenofibrate Dispersible Tablets are contraindicated in patients who are allergic to the ingredients contained in them, in patients with a history of gallbladder disease, cholelithiasis, severe renal insufficiency, hepatic insufficiency, primary biliary cirrhosis, and persistent abnormalities of hepatic function of unspecified cause. The safety and efficacy of the drug in pregnant and lactating women, as well as in children, are not known and therefore the use of this drug is contraindicated. If you need to use Fenofibrate Dispersible Tablets, it is recommended to consult a professional doctor and follow the doctor’s instructions for standardized treatment, and not blindly use the drug on your own.